Clinical trial
Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors
NCT00006477 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00006477 |
|---|---|
| Title | Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors |
| Official title | Phase I Clinical Trial of Recombinant Viscumin (rVISCUMIN, rMISTLETOE LECTIN, rML) Administered Twice Weekly by the Subcutanous Route in Patients With Solid Tumors After Failure of Standard Therapy |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Dietary Supplement |
| Interventions | mistletoe extract |
| Enrollment | 26 |
| Start date | Sep 1, 2000 |
| Primary completion | Jun 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 18, 2012 |
| Countries | Germany, Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: